PeptideDB

LMPTP INHIBITOR 1 dihydrochloride

CAS No.: 2310135-46-5

LMPTP Inhibitor 1 Dihydrochloride is a compound selectively targeting low molecular weight protein tyrosine phosphatase
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description LMPTP Inhibitor 1 Dihydrochloride is a compound selectively targeting low molecular weight protein tyrosine phosphatase (LMPTP), exhibiting potent inhibitory activity with an IC50 value of 0.8 μM for LMPTP-A.
In vitro LMPTP INHIBITOR 1 dihydrochloride is a selective inhibitor of low molecular weight protein tyrosine phosphatase, with an IC50?of 0.8 μM LMPTP-A and shows more potent effect on LMPTP-A versus LMPTP-B. LMPTP inhibitor 1 dihydrochloride (10 μM) also enhances HepG2 IR phosphorylation after insulin stimulation in human HepG2 hepatocytes[1].
In vivo LMPTP inhibitor 1 dihydrochloride is orally bioavailable, and results in appr 680 nM mean serum concentration after treatment of 0.03% w/w, while treatment with 0.05% w/w results in >3 μM; also reverses diabetes in obese mice. LMPTP inhibitor 1 dihydrochloride (0.05% w/w) inhibits LMPTP activity, significantly improves glucose tolerance and decreases fasting insulin levels of diabetic DIO mice, without affecting body weight[1].
Target activity LMPTPA:0.8 μM
molecular weight 517.53
Molecular formula C28H38Cl2N4O
CAS 2310135-46-5
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility H2O: 50 mg/mL (96.61 mM), Sonication is recommended. DMSO: 64 mg/mL (123.66 mM)